| Mazen Nashed, MD | |
|
527 Medical Park Drive, Suite 204, Bridgeport, WV 26330 | |
| (304) 933-3800 | |
| (304) 933-3815 |
| Full Name | Mazen Nashed |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 43 Years |
| Location | 527 Medical Park Drive, Bridgeport, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124114574 | NPI | - | NPPES |
| 0640002000 | Medicaid | WV | |
| 000505915 | Other | WV | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | WV19485A (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wvu Medicine Home Health United Hospital Center | Clarksburg, WV | Home health agency |
| United Hospital Center | Bridgeport, WV | Hospital |
| West Virginia University Hospitals | Morgantown, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Specialists, Inc | 8022922699 | 5 |
News Archive
Smoking rates among teenagers can be reduced by training influential students within secondary schools to promote anti-smoking messages in their everyday conversations with their friends and peer group. This is the conclusion of authors of an article in this week's edition of The Lancet.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Alameda Alliance for Health, based in Alameda, Calif., has selected MedeAnalytics' Provider Network Management Analytics and Medical Management Analytics solutions. The Alliance will utilize these analytic solutions to improve member outcomes and services.
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to develop. The compound has been shown to be effective in treating mice with breast and prostate cancer and is now rapidly progressing towards the first clinical trials in patients.
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced that it filed today with the U.S. Government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy products.
› Verified 9 days ago
| Entity Name | Associated Specialists, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427165596 PECOS PAC ID: 8022922699 Enrollment ID: O20031118000229 |
News Archive
Smoking rates among teenagers can be reduced by training influential students within secondary schools to promote anti-smoking messages in their everyday conversations with their friends and peer group. This is the conclusion of authors of an article in this week's edition of The Lancet.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Alameda Alliance for Health, based in Alameda, Calif., has selected MedeAnalytics' Provider Network Management Analytics and Medical Management Analytics solutions. The Alliance will utilize these analytic solutions to improve member outcomes and services.
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to develop. The compound has been shown to be effective in treating mice with breast and prostate cancer and is now rapidly progressing towards the first clinical trials in patients.
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced that it filed today with the U.S. Government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy products.
› Verified 9 days ago
| Entity Name | United Hospital Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760965586 PECOS PAC ID: 8123936010 Enrollment ID: O20031212000802 |
News Archive
Smoking rates among teenagers can be reduced by training influential students within secondary schools to promote anti-smoking messages in their everyday conversations with their friends and peer group. This is the conclusion of authors of an article in this week's edition of The Lancet.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Alameda Alliance for Health, based in Alameda, Calif., has selected MedeAnalytics' Provider Network Management Analytics and Medical Management Analytics solutions. The Alliance will utilize these analytic solutions to improve member outcomes and services.
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to develop. The compound has been shown to be effective in treating mice with breast and prostate cancer and is now rapidly progressing towards the first clinical trials in patients.
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced that it filed today with the U.S. Government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy products.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mazen Nashed, MD 527 Medical Park Drive, Suite 204, Bridgeport, WV 26330 Ph: (304) 933-3800 | Mazen Nashed, MD 527 Medical Park Drive, Suite 204, Bridgeport, WV 26330 Ph: (304) 933-3800 |
News Archive
Smoking rates among teenagers can be reduced by training influential students within secondary schools to promote anti-smoking messages in their everyday conversations with their friends and peer group. This is the conclusion of authors of an article in this week's edition of The Lancet.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Alameda Alliance for Health, based in Alameda, Calif., has selected MedeAnalytics' Provider Network Management Analytics and Medical Management Analytics solutions. The Alliance will utilize these analytic solutions to improve member outcomes and services.
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to develop. The compound has been shown to be effective in treating mice with breast and prostate cancer and is now rapidly progressing towards the first clinical trials in patients.
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced that it filed today with the U.S. Government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy products.
› Verified 9 days ago
Dr. Michael T. Angotti, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Dr, Suite 307, Bridgeport, WV 26330 Phone: 304-933-3332 Fax: 304-933-3318 | |
Brandon Shiflett, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1000 | |
Nabeel Ghabra, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Dr Ste 402, Bridgeport, WV 26330 Phone: 681-342-3690 Fax: 681-342-3695 | |
Salma Khatoon, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 681-342-1852 | |
Dr. Nathaniel James Kesner, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 327 Medical Park Dr, Bridgeport, WV 26330 Phone: 304-623-1330 | |
Dr. Susan W. Miller, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 140 W Main St, Bridgeport, WV 26330 Phone: 304-842-2206 Fax: 304-842-2580 | |
Mrs. Kimberly J Fairley, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Dr Ste 402, Bridgeport, WV 26330 Phone: 681-342-3690 |